These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18687022)

  • 1. Parkinsonism and akathisia with quetiapine: three case reports.
    Bharadwaj R; Grover S
    J Clin Psychiatry; 2008 Jul; 69(7):1189-91. PubMed ID: 18687022
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutropenia associated with the comedication of quetiapine and valproate in 2 elderly patients.
    Hung WC; Hsieh MH
    J Clin Psychopharmacol; 2012 Jun; 32(3):416-7. PubMed ID: 22561472
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine-induced acute dystonia and akathisia.
    Desarkar P; Sinha VK
    Aust N Z J Psychiatry; 2006; 40(6-7):607-8. PubMed ID: 16756588
    [No Abstract]   [Full Text] [Related]  

  • 4. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.
    Fond G; MacGregor A; Ducasse D; Brittner M
    Psychiatry Res; 2014 May; 216(2):286-7. PubMed ID: 24582773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cataracts and quetiapine.
    Valibhai F; Phan NB; Still DJ; True J
    Am J Psychiatry; 2001 Jun; 158(6):966. PubMed ID: 11384916
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy.
    Bora E; Saffet Gonul A; Akdeniz F; Vahip S
    Eur Psychiatry; 2003 Oct; 18(6):323. PubMed ID: 14611931
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotic agents ineffective for AD.
    Duke Med Health News; 2007 Jan; 13(1):8. PubMed ID: 17299888
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation.
    Villari V; Rocca P; Fonzo V; Montemagni C; Pandullo P; Bogetto F
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):405-13. PubMed ID: 17900775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone.
    Mintzer JE; Mullen JA; Sweitzer DE
    Curr Med Res Opin; 2004 Sep; 20(9):1483-91. PubMed ID: 15383198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of pancytopenia with quetiapine use.
    Iraqi A
    Am J Geriatr Psychiatry; 2003; 11(6):694. PubMed ID: 14609812
    [No Abstract]   [Full Text] [Related]  

  • 14. Quetiapine for hypnogogic musical release hallucinations.
    David RR; Fernandez HH
    J Geriatr Psychiatry Neurol; 2000; 13(4):210-1. PubMed ID: 11128061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotics and mortality in Parkinsonism.
    Marras C; Gruneir A; Wang X; Fischer H; Gill SS; Herrmann N; Anderson GM; Hyson C; Rochon PA
    Am J Geriatr Psychiatry; 2012 Feb; 20(2):149-58. PubMed ID: 22273735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 17. The new antipsychotic compounds: is a clinical choice algorithm possible?
    Wirshing WC
    West J Med; 1998 Jul; 169(1):43-4. PubMed ID: 9682633
    [No Abstract]   [Full Text] [Related]  

  • 18. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
    Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA;
    N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine in the treatment of patients with resistant auditory hallucinations: two case reports with long-term cognitive assessment.
    Mosolov SN; Kabanov S
    Eur Psychiatry; 2005 Aug; 20(5-6):430. PubMed ID: 15961291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.